Dear Editor,
We read with interest the paper by Akihiko Matsumoto dealing with preoperative chronic kidney disease as a predictor of oncological outcomes of radical cystectomy for bladder cancer [1] .
We are grateful to the authors for their innovative study and recognize that they should be commended for their attempt to provide a scientific support to an idea with a fascinating biological rationale. However, we would like to point out several limitations of the study that in our opinion make the results rather difficult to apply to clinical practice. is not a precise practice. As we know, more effective chemotherapeutic regimens (such the cisplatin-based chemotherapy) cannot be administered to patients with impaired renal function and this difference in chemotherapy (CHT) regimens could act as a confounder [5] .
In our opinion, future studies on this subject must provide more details of potential confounding factors to clarify the magnitude of this biological phenomenon. Moreover, the development of effective medical therapies for patients who cannot undergo conventional CHT because of impaired renal function is clearly needed.
